EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Background: Epidermal growth factor receptor (EGFR) mutation testing is recommended in metastatic non-small cell lung cancer (NSCLC). The objective of this study was to assess changes in EGFR mutation testing patterns and tyrosine kinase inhibitor (TKI) use in US veterans with stage III-IV NSCLC bet...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cancer Treatment and Research Communications
المؤلفون الرئيسيون:	Anna Hung, Kyung Min Lee, Patrick R. Alba, Yanhong Li, Anthony Z. Gao, Bradley J. Hintze, Olga V. Efimova, Rahul Shenolikar, Melissa Pavilack, Dan Simmons, Michael J. Kelley, Julie A. Lynch, Shelby D. Reed
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2021-01-01
الموضوعات:	Cancer genomics Targeted drug therapy
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2468294221000265